The Tudor Dixon Podcast: Ozempic Era Explained—GLP-1 Risks, Weight Loss Truths

What’s really behind the “Ozempic era”—and is it changing how America thinks about weight, health, and discipline?

On this episode of The Tudor Dixon Podcast, Tudor sits down with weight loss expert Dr. Tom Lavin to break down the truth about GLP-1 medications like Ozempic and Wegovy. From Hollywood’s sudden transformation to everyday Americans turning to injections, this conversation goes beyond the hype to uncover the real risks, benefits, and long-term consequences.

They discuss how GLP-1 drugs actually work in the brain, why they’re being called a game-changer for obesity, and the growing concerns around misuse—especially among already-thin individuals. Dr. Lavin explains why these medications aren’t a magic fix, the importance of maintaining muscle mass, and how improper use can lead to serious health issues.

Plus, they dive into the surprising link between GLP-1s and addiction control, the lack of medical oversight in today’s fast-growing weight loss industry, and what patients should be asking before starting treatment.

If you’ve been curious about Ozempic, weight loss injections, or the future of metabolic health, this is a must-listen conversation.

Follow Clay & Buck on YouTube: https://www.youtube.com/c/clayandbuck

See omnystudio.com/listener for privacy information.